Pharma Journalist - Page 805 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

AstraZeneca and Merck asserted the approval of LYNPARZA tablets for patients with Ovarian Cancer

Opdivo along with Yervoy displays treatment for dMMR or MSI-H patients with mCRC

Alberto Garotti appointed Chief Financial Officer by Selexis SA

Biohaven initiates clinical investigation of BHV-5000 as directed by FDA

FDA accepts Aquestive Therapeutic’s NDA for clobazam OSF treating LGS patients

QIAGEN sought FDA approval for QIAGEN’s therascreen EGFR RGQ PCR Kit for NSCLC

Bluegrass Vascular declares enrollment of first patients for SAVE-US Pivotal Trial

OncoSec Medical proclaims preliminary clinical observations of OMS-1140 Clinical Trial of ImmunoPulse in TNBC patients